T cell receptor ξ chain: a biological marker for predicting the therapeutic response to tumour necrosis factor blockade in patients with rheumatoid arthritis

张卓莉,李光韬,周炜,王昱,郝燕捷

DOI: https://doi.org/10.3760/cma.j.issn.1007-7480.2009.12.006

2009-01-01

Abstract:Objective To explore the potentials of T cells with low expression of ξ(TCRξ~(dim) cells there-after)as a predictor for the therapeutic response to tumor necrosis factor blockade in patients with rheumatoid arthritis(RA).Methods Twelve active serological positive RA patients(DAS28＞5.1)were recruited and treated with standard protocol of Remicade.At week 14 and week 30.the therapeutic responses to treatment of the patients were assessed as good responders,moderate responders or poor responders.The TCR ξ expression in different subpopulation of peripheral lymphocytes was analyzed by flow cytometry at baseline,week 14 and week 30.Results TCR ξ~(dim) T cells possessed strong migration capability and selectively moved from circulation to the inflammatoty sites,which lcad to significandy increased TCR ξ~(dim) cells in synovial fluid compared to peripheral blood in RA patients(P＜0.05).According to EULAR therapeutic response criteria,3 patients(3/12,25%)were good responders,6 patients(6/12,50%)were moderate responders and 3 patients(3/12,25%)were poor responders at weak 30.The accumulation of CD4~+TCR ξ~(dim) T cells in peripheral blood at week 14 was detected in those good responders、however not in those poor responders.The percentage of changes of TCR ξ~(dim) T cells at week 14 was closely correlated to DAS28 score at week 30(r~2=0.6835,P＜0.01).Conclusion Tumor necrosis factor blockade is effective in the treatment of rheumatoid arthritis.The change of peripheral TCR ξ dim T cells at week 14 can predict the therapeutic response at week 30 in RA patients.Blockade the migration of TCR ξ~(dim) T lymphocytes from circulation into the ioint is one of the important mechanisms of tumor necrosis factor blockade in the treatment of RA.